Goodhew
Erica B. Goodhew, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20080213319 | CHEMOREPULSION OF CELLS - The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes. | 09-04-2008 |
20100203087 | CHEMOREPULSION OF CELLS - The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes. | 08-12-2010 |
Erica Brook Goodhew, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20100093677 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of idebenone, benazepril, rolipram, moxonidine, lamivudine, loxoprofen, terbinafine, Synephrine, 6-aminoindazole, and a Vitamin D analog, or a pharmaceutically acceptable salt of any of thereof. | 04-15-2010 |
20100093747 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound having the Formula (I), (II), (III) or (IV). | 04-15-2010 |
20140031321 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of idebenone, benazepril, rolipram, moxonidine, lamivudine, loxoprofen, terbinafine, synephrine, 6-aminoindazole, and a Vitamin D analog, or a pharmaceutically acceptable salt of any of thereof. | 01-30-2014 |
Iain Goodhew, London GB
Karl David Goodhew, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20120084108 | SYSTEMS AND METHODS FOR A WORK FLOW MANAGEMENT APPLICATION SUITE FOR MOBILE COMMUNICATIONS DEVICES - Systems and methods for a work flow management application suite for mobile communications devices are provided. In one embodiment, a method for providing work flow management from a mobile communication unit comprises: initiating a login from the mobile communication unit to a back-end database by transmitting a unique device ID for the mobile communication unit, a username and password to a supervisory server; when the logon is granted, retrieving project information records from the back-end database for one or more projects assigned to the username; and displaying on the mobile communication unit a schedule of project information for the one or more projects based on the project information records, wherein the project information includes a Method of Procedure (MOP) status for each of the one or more projects, the MOP status indicating whether a MOP to perform a work task is currently valid. | 04-05-2012 |
William Goodhew, Ithaca, NY US
Patent application number | Description | Published |
---|---|---|
20110132372 | INTRA-NASAL AIR FILTRATION DEVICES AND METHODS - An intra-nasal air filtration device includes a filter material. The filter material is sized to fit a nasal vestibule of a user, is resilient such that it expands after compression for insertion into the nasal vestibule, and blocks passage of airborne particles while permitting passage of air during inhalation by the user. The filter material preferably includes a plurality of synthetic fibers. In some embodiments, the filter material has a density and texture similar to that of a natural sea sponge. In some embodiments, particles of activated charcoal are bonded to the fibers and a synthetic fabric is bonded to at least a portion of an outer surface of the synthetic fibers. A method of manufacturing an intra-nasal air filtration device, a method of filtering airborne particles from an air stream, and a method of enhancing breathing of an individual are also disclosed. | 06-09-2011 |